ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 709,66
-0,02%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Longeveron Inc (LGVNR)

  7. Longeveron Inc (LGVNR) Actualités

LGVNR

Longeveron (LGVNR)

Longeveron Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:LGVNR
DateHeureSourceTitreSymboleSociété
28/05/202414h05GlobeNewswire Inc.Longeveron® to Attend BIO International Convention 2024NASDAQ:LGVNRLongeveron Inc
22/05/202423h28Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:LGVNRLongeveron Inc
21/05/202422h09Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:LGVNRLongeveron Inc
20/05/202422h19Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:LGVNRLongeveron Inc
20/05/202422h18Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:LGVNRLongeveron Inc
20/05/202422h09Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:LGVNRLongeveron Inc
14/05/202422h05GlobeNewswire Inc.Longeveron Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:LGVNRLongeveron Inc
14/05/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LGVNRLongeveron Inc
10/05/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LGVNRLongeveron Inc
10/05/202422h05GlobeNewswire Inc.Longeveron Announces Board of Directors Planned TransitionsNASDAQ:LGVNRLongeveron Inc
07/05/202400h59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGVNRLongeveron Inc
02/05/202414h03GlobeNewswire Inc.Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024NASDAQ:LGVNRLongeveron Inc
25/04/202422h05GlobeNewswire Inc.Longeveron to Present at the Planet MicroCap ShowcaseNASDAQ:LGVNRLongeveron Inc
25/04/202419h02Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:LGVNRLongeveron Inc
18/04/202422h05GlobeNewswire Inc.Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public OfferingNASDAQ:LGVNRLongeveron Inc
18/04/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LGVNRLongeveron Inc
17/04/202423h07Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:LGVNRLongeveron Inc
17/04/202414h00GlobeNewswire Inc.Longeveron Announces Exercise of Warrants for $6.2 Million Gross ProceedsNASDAQ:LGVNRLongeveron Inc
15/04/202414h30GlobeNewswire Inc.Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)NASDAQ:LGVNRLongeveron Inc
11/04/202423h17GlobeNewswire Inc.Longeveron Announces Closing of $5.2 Million Public OfferingNASDAQ:LGVNRLongeveron Inc
08/04/202420h15GlobeNewswire Inc.Longeveron Announces Pricing of $5.25 Million Public OfferingNASDAQ:LGVNRLongeveron Inc
08/04/202414h45Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:LGVNRLongeveron Inc
08/04/202414h30GlobeNewswire Inc.Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and GoalsNASDAQ:LGVNRLongeveron Inc
19/03/202422h14Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:LGVNRLongeveron Inc
11/03/202421h01Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:LGVNRLongeveron Inc
27/02/202422h05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:LGVNRLongeveron Inc
25/01/202423h16Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:LGVNRLongeveron Inc
22/12/202314h36Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:LGVNRLongeveron Inc
 Showing the most relevant articles for your search:NASDAQ:LGVNR

Dernières Valeurs Consultées

LSE
39YO
Res.mtg 18 B1as
LSE
XRSU
Xrusl 2000 1c
EU
PACBB
Reg Provence Alpes Cote ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés